Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

The Generative AI Market is slated to expand from USD 71.36 billion in 2025 to USD 890.59 billion by 2032, at a substantial ...

Rajnish Gupta reveals how CIOs can tackle hidden risks in cloud AI—from privilege sprawl to data leaks and insecure machine ...

For Uditi’s parents, reading about use of CRISPR tech, or ‘genetic scissors’, to treat baby KJ, diagnosed with severe genetic ...

India already has a homegrown CAR T-cell therapy, and other regions are exploring their own strategies, including developing them at the point of care.

Scientists are seeking new grant opportunities, founding their own for-profit ventures, and exploring other approaches to ...

VertexMemory is your memory layer for LLMs using Google Vertex AI Vector Search - private, portable, open-source MCP Server. Your memories live locally, giving you complete control over your data.